Cargando…
LC-MS biomarker diagnostics for neuroinflammatory disorders
Autores principales: | Morrens, M., Coppens, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980703/ https://www.ncbi.nlm.nih.gov/pubmed/35378378 http://dx.doi.org/10.1016/j.ebiom.2022.103984 |
Ejemplares similares
-
Vascular mechanisms and manifestations of COVID-19
por: Levi, Marcel, et al.
Publicado: (2021) -
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020) -
LC–MS-MS Analysis of Urinary Biomarkers of Imazalil Following Experimental Exposures
por: Faniband, Moosa H., et al.
Publicado: (2015) -
Exploring potential biomarkers for lung adenocarcinoma using LC-MS/MS
metabolomics
por: Mo, Liang, et al.
Publicado: (2020) -
CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders
por: Perdaens, Océane, et al.
Publicado: (2020)